Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for...

Area of Science:

• Molecular Biology
• Oligonucleotide Therapeutics
• Cellular Biology

Background:

• Locked nucleic acid antisense oligonucleotides (LNA-ASOs) offer direct intracellular RNA targeting without delivery systems.
• Cellular uptake involves endosomal pathways and subsequent cytosolic/nuclear translocation.
• The precise quantity of LNA-ASOs required for effective target knockdown remains undetermined.

Purpose of the Study:

• To quantify the number of LNA-ASO molecules necessary for significant target RNA knockdown.
• To investigate the intracellular fate and distribution of LNA-ASOs.
• To identify factors influencing LNA-ASO efficacy and potency.

Main Methods:

• Quantitative fluorescence imaging of LNA-ASOs.
• Microinjection of LNA-ASOs into cell cytosol.
• Assessment of unassisted LNA-ASO cellular uptake.
• Evaluation of target knockdown with and without co-administered non-specific LNA-ASOs.

Main Results:

• Approximately 10^5 LNA-ASO molecules achieved >50% target knockdown, indicating significant endosomal escape.
• Microinjected LNA-ASOs rapidly translocated to the nucleus and bound to nuclear components.
• Blocking non-specific binding sites reduced the required LNA-ASO amount by tenfold.
• Only a small fraction of LNA-ASOs is available for RNase H1-mediated target reduction.

Conclusions:

• Intracellular dynamics, particularly within the nucleus, significantly influence LNA-ASO distribution and activity.
• A substantial portion of cellular LNA-ASOs may not be actively engaged in target reduction.
• Optimizing LNA-ASO delivery and minimizing non-specific binding are crucial for enhancing therapeutic efficacy.